Shopping Cart
Remove All
Your shopping cart is currently empty
Trimetazidine is a non-haemodynamic antianginal agent that selectively inhibits the mitochondrial enzyme 3-ketoacyl coenzyme A thiolase (LC 3-KAT), thereby preventing β-oxidation of free fatty acids, with an IC50 value of 75 nM. Trimetazidine prevents ischaemia-reperfusion injury by altering cardiac metabolism, exhibiting antioxidant and anti-ischaemic effects.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $32 | - | In Stock | |
| 10 mg | $44 | In Stock | In Stock | |
| 25 mg | $57 | In Stock | In Stock | |
| 50 mg | $70 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | - | In Stock |
| Description | Trimetazidine is a non-haemodynamic antianginal agent that selectively inhibits the mitochondrial enzyme 3-ketoacyl coenzyme A thiolase (LC 3-KAT), thereby preventing β-oxidation of free fatty acids, with an IC50 value of 75 nM. Trimetazidine prevents ischaemia-reperfusion injury by altering cardiac metabolism, exhibiting antioxidant and anti-ischaemic effects. |
| Targets&IC50 | Long chain 3-ketoyl coenzyme A thiolase:75 nM |
| In vitro | Methods: Mouse C2C12 myoblasts were treated with Trimetazidine (50–200 μM, 6 hours), and cell viability was measured using CCK-8 reagent. Result: Trimetazidine at concentrations of 150 μM and 200 μM significantly reversed dexamethasone-induced cell death.[1] |
| In vivo | Methods: Trimetazidine (5 mg/kg, administered intraperitoneally for 12 consecutive days) was injected into C26 colon carcinoma mice to study the "exercise-mimicking" effects of trimetazidine in a cancer cachexia mouse model. Results: Trimetazidine enhanced metabolic adaptive mechanisms in cancer cachexia mice by mimicking the effects of exercise, including increased grip strength, elevated proportion of slow muscle fibers, upregulated PGC1α expression, and enhanced mitochondrial biogenesis and oxidative metabolism. [2] |
| Molecular Weight | 266.34 |
| Formula | C14H22N2O3 |
| Cas No. | 5011-34-7 |
| Smiles | COc1ccc(CN2CCNCC2)c(OC)c1OC |
| Relative Density. | 1.092 g/cm3 |
| Color | White |
| Appearance | Viscous |
| Storage | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 85.00 mg/mL (319.14 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (12.39 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.